Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Thinly traded nanocap biotech Seelos Therapeutics Inc (NASDAQ: SEEL ) is trading sharply higher on over three times its average volume. The company recently completed a reverse merger with Apricus Bio

Read more

Seelos Therapeutics Inc (NASDAQ:SEEL) stock rocketed in pre-market trade Friday after the New York-based biopharmaceutical company shared details about the benefits of its reverse merger with Apricus

Read more

Ligand Pharmaceuticals Partner Seelos Therapeutics, Inc. recently achieved a major milestone by going public via a reverse merger with Apricus Biosciences, Inc.

Read more

Erectile Dysfunction Drugs Market Size: The report, named “Global Erectile Dysfunction Drugs Market 2019”, provides a Detailed overview of the Erectile Dysfunction Drugs Market related to overall

Read more

Global Raynauds Disease Treatment Market has been effectuating the national economic structure along with its peer and parent markets globally. Considering its performance for more than a decade, the

Read more

The stock of Apricus Biosciences Inc (NASDAQ:APRI) registered a decrease of 13.68% in short interest. APRI's total short interest was 1.27 million shares in

Read more

Apricus Biosciences Inc (NASDAQ:APRI) saw a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,699,355 shares, a growth of 32.3%

Read more

Shares of Apricus Biosc Inc (APRI) have been trending lower over the past five bars, revealing bearish momentum for the shares, as they ran -18.48% for the week. Looking further out we note that the s

Read more

The DAX managed a slight gain of 0.20%, while the FTSE 100 was underperforming after strong labor market data lifted yields. The index has lifted off lows, but remains down 0.42% on the day. Stocks we

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week peaks Thursday. Down In The Dumps (Biotech stocks hitting 52-week lows on Jan. 24) Amnea

Read more

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Seelos Therapeutics, Inc. (NASDAQ: SEEL) announced that it has closed a reverse merger with Apricus Biosciences, Inc.

Read more

Seelos Therapeutics (Nasdaq:SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patient

Read more

NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to add

Read more

When applying indicators for technical analysis, traders and investors might want to examine the ATR or Average True Range. The current 14-day ATR for Apricus Biosciences, Inc. (NASDAQ:APRI) is curren

Read more

Apricus Biosc Inc (APRI) are being closely watched by investors as the firm’s Mesa Adaptive Moving Average (MAMA) has dipped below the Fractional Adaptive Moving Average (FAMA), indicating that a po

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank